190 related articles for article (PubMed ID: 35685240)
1. Long Non-Coding RNA AP000695.2 Acts as a Novel Prognostic Biomarker and Regulates the Cell Growth and Migration of Lung Adenocarcinoma.
Wang C; Guo J; Jiang R; Wang C; Pan C; Nie Z; Jiang X
Front Mol Biosci; 2022; 9():895927. PubMed ID: 35685240
[TBL] [Abstract][Full Text] [Related]
2. LncRNA AP000695.2 promotes glycolysis of lung adenocarcinoma via the miR-335-3p/TEAD1 axis.
Xu S; Cheng Z; Du B; Diao Y; Li Y; Li X
Acta Biochim Biophys Sin (Shanghai); 2023 Oct; 55(10):1592-1605. PubMed ID: 37723874
[TBL] [Abstract][Full Text] [Related]
3. LncRNA-AC02278.4 Is a Novel Prognostic Biomarker That Promotes Tumor Growth and Metastasis in Lung Adenocarcinoma.
Chen X; Zhou F; Ren W; Guo J; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():860961. PubMed ID: 35463380
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA AP000695.2 as a Novel Prognostic Biomarker for Gastric Cancer.
Cheng Y; Yi X; Fu S; Cheng J; Li W; Xu H
Discov Med; 2023 Feb; 35(174):28-35. PubMed ID: 37024439
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma.
Jiang A; Liu N; Bai S; Wang J; Gao H; Zheng X; Fu X; Ren M; Zhang X; Tian T; Ruan Z; Liang X; Yao Y
J Thorac Dis; 2021 Feb; 13(2):720-734. PubMed ID: 33717544
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma.
Chen X; Guo J; Zhou F; Ren W; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():905871. PubMed ID: 35651789
[TBL] [Abstract][Full Text] [Related]
7. Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma.
Chen X; Guo J; Zhou F; Ren W; Pu J; Mutti L; Niu X; Jiang X
Front Oncol; 2022; 12():895708. PubMed ID: 35646670
[TBL] [Abstract][Full Text] [Related]
8. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma.
Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C
Front Oncol; 2022; 12():921200. PubMed ID: 35774125
[TBL] [Abstract][Full Text] [Related]
10. Identification of immune-associated lncRNAs as a prognostic marker for lung adenocarcinoma.
He C; Yin H; Zheng J; Tang J; Fu Y; Zhao X
Transl Cancer Res; 2021 Feb; 10(2):998-1012. PubMed ID: 35116427
[TBL] [Abstract][Full Text] [Related]
11. Identification and verification of a prognostic ferroptosis-related lncRNAs signature for patients with lung adenocarcinoma.
Qi K; Liu XL; Chen XL; Song C; Peng JH; Xu JJ
Am J Transl Res; 2022; 14(6):3698-3715. PubMed ID: 35836852
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-AC068228.1 Is a Novel Prognostic Biomarker That Promotes Malignant Phenotypes in Lung Adenocarcinoma.
Jiang X; Chen M; Du J; Bi H; Guo X; Yang C; He X; Jin Z
Front Oncol; 2022; 12():856655. PubMed ID: 35280807
[TBL] [Abstract][Full Text] [Related]
13. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator.
Jiang X; Chen X; Guo J; Zhou F; Pu J; Mutti L; Niu X
Front Mol Biosci; 2022; 9():923584. PubMed ID: 35769906
[TBL] [Abstract][Full Text] [Related]
15. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
Yu L; Qiao R; Xu J; Han B; Zhong R
Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
[TBL] [Abstract][Full Text] [Related]
16. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
[TBL] [Abstract][Full Text] [Related]
17.
Zheng Y; Zhang Z; Li X; Wu L; Liu X; Liu L; Chen J; Wei D
Front Biosci (Landmark Ed); 2023 Oct; 28(10):257. PubMed ID: 37919058
[TBL] [Abstract][Full Text] [Related]
18. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
19. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
Zhao J; Lin X; Zhuang J; He F
Front Genet; 2021; 12():714697. PubMed ID: 34777460
[No Abstract] [Full Text] [Related]
20. A novel long noncoding RNA AC092718.4 as a prognostic biomarker and promotes lung adenocarcinoma progression.
Chen S; Yu Y; Yuan Y; Chen X; Zhou F; Li Y; Wang P; Jiang X; Tian S; Ren W
Aging (Albany NY); 2022 Dec; 14(24):9924-9941. PubMed ID: 36490353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]